微波消融与保留乳头乳晕复合体改良根治术治疗早期乳腺癌的对比倾向性评分匹配分析

Microwave ablation versus modified radical treatment with preserved nipple sparing mastectomy for early breast cancer:a propensity score-matched analysis

目的比较超声引导下微波消融(MWA)与保留乳头乳晕复合体改良根治术(NSM)治疗早期乳腺癌(T_(0/1/2) N_(0/1) M_(0))的可行性和有效性。方法回顾性分析本院2014年1月~2020年1月进行MWA或NSM治疗的83例早期乳腺癌患者,其中MWA组30例,NSM组53例。通过倾向性评分匹配按1∶1平衡两组基线特征。主要评价指标为肿瘤进展,次要评价指标包括总生存、美容满意度和并发症。结果倾向性评分匹配前平均肿瘤大小2.3 cm(0.3~5.0 cm);倾向性评分匹配后两组患者各19例,基线特征平衡。中位随访时间34.1(四分位数23.1~41.1)月。所有肿瘤均取得技术成功。转移性淋巴结处理,两组各消融/切除腋窝淋巴结4例(4/19,21.0%)。MWA组术后辅助全身性治疗比NSM组少(36.8%vs 73.7%,P=0.02)。共有6例发生肿瘤进展,其中MWA组3例,NSM组3例。MWA组术后42月发生1例局部肿瘤进展,28月发生1例同侧乳房转移,32.8月发生1例脑转移;NSM术后10.2月、31.2月各发生1例同侧乳房转移,34月发生1例骨转移,两组肿瘤进展差异无统计学意义(P=0.68)。两组均无乳腺癌相关死亡和严重并发症(P>0.05)。但MWA组手术时间短(32 min vs 133 min,P<0.001)、术后住院时间短(3 d vs 5 d,P<0.001)、美容满意度更好(P<0.001)。结论在早期乳腺癌患者中,中位随访期间MWA取得了与NSM相似的治疗效果及更好的美容满意度,MWA为不愿或不耐受手术患者提供了微创安全可耐受的局部治疗选择。

Objective To compare the feasibility and effectiveness of ultrasound-guided microwave ablation(MWA)and nipple sparing mastectomy(NSM)for early breast cancer(T_(0/1/2) N_(0/1) M_(0)).Methods Retrospective analysis of 83 patients with early breast cancer who underwent MWA or NSM from January 2014 to January 2020 in our hospital.including 30 patients in the MWA group and the other 53 patients in the NSM group.Propensity score matching was performed at 1∶1 to balance the baseline characteristics.The primary evaluation metric was tumor progression in the intention-to-treat population,and secondary evaluation metrics included overall survival,cosmetic satisfaction and complications.Results Before propensity score matching The mean tumor size was 2.3 cm(0.3-5.0 cm).After propensity score matching,each group had 19 patients and the baseline characteristic were balanced.Median follow-up was 34.1 months(IQR 23.1-41.1 months).All the tumors achieved technique effectiveness.For the management of metastatic lymph nodes,4 axillary lymph nodes were ablated/resected in both groups(4/19,21.0%).There were fewer adjuvant systemic postoperative treatments in the MWA group than in the NSM group(36.8%vs 73.7%,P=0.02).A total of 6 cases of tumour progression occurred,including 3 in the MWA and 3 in the NSM.One local tumor progression occurred in the MWA group at 42 mouths,one ipsilateral breast recurrence occurred at 28 months and 1 case of brain metastasis at 32.8 months after MWA.1 case of ipsilateral breast metastasis at 10.2 months and 1 case of bone metastasis at 31.2 months and 1 case of bone metastasis at 34 months postoperatively in the NSM group.Two groups had no significant difference in tumor progression(P=0.68).No participants in both groups developed cancer related death and major complications(P>0.05).MWA achieves similar outcomes to NSM and better cosmetic satisfaction during median follow-up in patients with early-stage breast cancer,and that who do not want or are intolerant of surgery.However,MWA had a shorter operation time(32 min vs 133 min,P<0.001),a shorter postoperative hospital stay(3 d vs 5 d,P<0.001)and better beauty satisfaction(P<0.001).Conclusion Preliminary study showed that in selected early breast cancer patients,MWA has achieved similar outcomes to early breast cancer treatment and better aesthetic satisfaction as NSM during an intermediate follow-up.MWA offers a minimally invasive,safe and tolerable local treatment option for patients who reluctant or intolerant to breastconserving surgery.